title: [Role of blue-light cystoscopy in the management of non-muscle invasive bladder cancer].
abstract: Blue-light cystoscopy aims to facilitate the detection of bladder tumors in order to optimize the completeness of resection. We performed a literature analysis using data from Medline and according to PRISMA guidelines. Several meta-analyses have confirmed the interest of the blue-light cystoscopy in terms of improved detection rate and disease-free survival compared to standard white-light cystoscopy. These benefits outweigh the initial costs related to the acquisition of specific equipment, allowing an improvement in quality-adjusted life-years and a reduction of costs over time. Indications vary according to guidelines and must take into account equipment and logistic constraints on each center. The objective of this article is to make a focus on the role and the interest of blue-light cystoscopy in the management of NMIBC in 2015.
authors.affiliation: Service d'urologie, hôpital Bicêtre, université Paris-Sud, 78, rue du Général-Leclerc, 94270 Le Kremlin-Bicêtre, France. Electronic address: gg_pignot@yahoo.fr.
authors.forename: G
authors.initials: G
authors.lastname: Pignot
mesh_terms: D003558:Cystoscopy / Q000379:methods*; D006801:Humans; D009361:Neoplasm Invasiveness; D001749:Urinary Bladder Neoplasms / Q000473:pathology*
keywords: Cost-effectiveness; Coût–efficacité; Cystoscopie; Cystoscopy; Diagnosis; Diagnostic; Indications; Non-muscle invasive bladder cancer; Recurrence; Récidive; Tumeurs de vessie non infiltrant le muscle